Open AccessLymphocutaneous nocardiosis in a kidney transplant patient successfully treated with tigecycline
Author(s) -
Eleni Mylona,
Vassilios Papastamopoulos,
Myrto Giannopoulou,
Efstathia Perivolioti,
Zoi Psaroudaki,
Athanasios Skoutelis
Publication year - 2018
Publication title -
saudi journal of kidney diseases and transplantation/našrat amraḍ wa zira'aẗ al-kulaẗ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 30
eISSN - 2320-3838
pISSN - 1319-2442
DOI - 10.4103/1319-2442.243954
Subject(s) - tigecycline , medicine , nocardiosis , kidney transplantation , renal transplant , trimethoprim , minocycline , sulfamethoxazole , dermatology , surgery , antibiotics , transplantation , microbiology and biotechnology , nocardia , genetics , bacteria , biology
Cutaneous nocardiosis is an infrequent infection which has been increasingly reported in immunocompromised patients. Although trimethoprim-sulfamethoxazole is considered to be the agent of choice for treatment of nocardiosis, newer antimicrobials such as tigecycline have been proven to be effective in vitro, as well. We report the first case of primary cutaneous nocardiosis in a renal transplant recipient having corresponded well to treatment with tigecycline.